Hikma Pharmaceuticals Plc Director/PDMR Shareholding (2500F)
May 21 2013 - 10:36AM
UK Regulatory
TIDMHIK
RNS Number : 2500F
Hikma Pharmaceuticals Plc
21 May 2013
Annex DTR3
Notification of Transactions of Directors/Persons Discharging
Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital
letters.
State whether the notification relates
to (i) a
transaction notified in accordance
with DTR 3.1.2 R,
(ii) a disclosure made in accordance
LR 9.8.6R(1) or
(iii) a disclosure made in accordance
with section 793 of the Companies
Name of the issuer Act (2006).
1. HIKMA PHARMACEUTICALS PLC 2. (i) & (iii)
---- ------------------------------------------ ---- --------------------------------------------
State whether notification relates
to a person
connected with a person discharging
managerial responsibilities/director
Name of person discharging managerial named in 3 and identify the connected
responsibilities/director person
3. RONALD GOODE 4. N/A
---- ------------------------------------------ ---- --------------------------------------------
Indicate whether the notification
is in respect of a holding of the Description of shares (including
person referred to in 3 or 4 above class), debentures or derivatives
or in respect of a nonbeneficial or financial instruments relating
interest 1 to shares
5. 3 ABOVE 6. ORDINARY SHARES OF 10P EACH
---- ------------------------------------------ ---- --------------------------------------------
Name of registered shareholders(s)
and, if more than one, the number State the nature of the transaction
of shares held by each of them
MARKET DISPOSAL OF 5,700 ORDINARY
7. RONALD GOODE 8. SHARES
---- ------------------------------------------ ---- --------------------------------------------
9. Number of shares, debentures or 10. Percentage of issued class acquired
financial (treasury shares of that class should
instruments relating to shares acquired not be taken into account when calculating
percentage)
N/A
N/A
---- ------------------------------------------ ---- --------------------------------------------
11. Number of shares, debentures or 12. Percentage of issued class disposed
financial (treasury shares of that class should
instruments relating to shares disposed not be taken into account when calculating
percentage)
5,700
0.003%
---- ------------------------------------------ ---- --------------------------------------------
13. Price per share or value of transaction 14. Date and place of transaction
5,700 AT $14.95 (APPROXIMATELY GBP9.83P) 21 MAY 2013, LONDON
---- ------------------------------------------ ---- --------------------------------------------
Total holding following notification
and total percentage holding following
notification (any treasury shares
should not be taken into account Date issuer informed of transaction
when calculating percentage)
15. 17,000 (0.0086%) 16. 21 May 2013
---- ------------------------------------------ ---- --------------------------------------------
If a person discharging managerial responsibilities has been
granted options by the issuer
complete the following boxes
Date of grant Period during which or date
on which exercisable
17. N/A 18. N/A
---- --------------------------- ---- -------------------------------
Description of shares or
Total amount paid (if any) debentures involved (class
for grant of the option and number)
19. N/A 20. N/A
---- --------------------------- ---- -------------------------------
Exercise price (if fixed
at time of grant) or Total number of shares or
indication that price is debentures over which options
to be fixed at the time held following notification
of exercise
21. N/A 22. N/A
---- --------------------------- ---- -------------------------------
Any additional information Name of contact and telephone
number for queries
23. N/A 24. Peter Speirs 0207 399 2772
---- --------------------------- ---- -------------------------------
Name of authorised official of issuer responsible for making
notification
Peter Speirs, Company Secretary
Date of notification 21 May 2013
-------------------------------------------------------------
Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.
(1) An issuer making a notification in respect of a transaction
relating to the shares or debentures of the issuer
should complete boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect of a derivative
relating the shares of the issuer should complete boxes
1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect of options
granted to a director/person discharging managerial
responsibilities should complete boxes 1 to 3 and 17
to 24.
(4) An issuer making a notification in respect of a financial
instrument relating to the shares of the issuer (other
than a debenture) should complete boxes 1 to 4, 6,
8, 9, 11, 13, 14, 16, 23 and 24.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBSGDUSXDBGXB
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
